Description
P21 Adamantane Modification represents an enhanced version of the P21 peptide incorporating adamantane conjugation designed to improve stability, bioavailability, and biological activity compared to the native P21 sequence. The adamantane modification provides enhanced resistance to enzymatic degradation and improved pharmacokinetic properties, making it suitable for extended research protocols. The compound maintains the cognitive-enhancing and neuroprotective properties of P21 while providing enhanced stability and potentially improved efficacy. P21 Adamantane functions through similar mechanisms to native P21, involving modulation of CREB signaling and enhancement of synaptic plasticity, but with improved stability and duration of action. Research applications include investigation of enhanced cognitive enhancement mechanisms, improved neuroprotection strategies, and the development of stabilized nootropic compounds for neurological research. For research use only.
Reviews
There are no reviews yet.